398 related articles for article (PubMed ID: 29197233)
1. Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress.
Li DJ; Fu H; Tong J; Li YH; Qu LF; Wang P; Shen FM
Redox Biol; 2018 May; 15():22-33. PubMed ID: 29197233
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
3. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall.
Bahnson ES; Koo N; Cantu-Medellin N; Tsui AY; Havelka GE; Vercammen JM; Jiang Q; Kelley EE; Kibbe MR
Nitric Oxide; 2015 Jan; 44():8-17. PubMed ID: 25460325
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic ACh receptor α7 inhibits PDGF-induced migration of vascular smooth muscle cells by activating mitochondrial deacetylase sirtuin 3.
Li DJ; Tong J; Zeng FY; Guo M; Li YH; Wang H; Wang P
Br J Pharmacol; 2019 Nov; 176(22):4388-4401. PubMed ID: 30270436
[TBL] [Abstract][Full Text] [Related]
6. α7 Nicotinic Acetylcholine Receptor Relieves Angiotensin II-Induced Senescence in Vascular Smooth Muscle Cells by Raising Nicotinamide Adenine Dinucleotide-Dependent SIRT1 Activity.
Li DJ; Huang F; Ni M; Fu H; Zhang LS; Shen FM
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1566-76. PubMed ID: 27339462
[TBL] [Abstract][Full Text] [Related]
7. α7 Nicotinic acetylcholine receptor contributes to the alleviation of lung ischemia-reperfusion injury by transient receptor potential vanilloid type 1 stimulation.
Li X; Xu Y; Cheng Y; Wang R
J Surg Res; 2018 Oct; 230():164-174. PubMed ID: 30100034
[TBL] [Abstract][Full Text] [Related]
8. Baroreflex deficiency aggravates atherosclerosis via α7 nicotinic acetylcholine receptor in mice.
Chen L; Liu DH; Zhang X; Zhang EH; Liu C; Su DF; Cai GJ
Vascul Pharmacol; 2016 Dec; 87():92-99. PubMed ID: 27568460
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of Long Pentraxin PTX3 Promoted Neointimal Hyperplasia after Vascular Injury.
Ishino M; Shishido T; Suzuki S; Katoh S; Sasaki T; Funayama A; Netsu S; Hasegawa H; Honda S; Takahashi H; Arimoto T; Miyashita T; Miyamoto T; Watanabe T; Takeishi Y; Kubota I
J Atheroscler Thromb; 2015; 22(4):372-8. PubMed ID: 25342475
[TBL] [Abstract][Full Text] [Related]
10. Vascular injury activates the ELK1/SND1/SRF pathway to promote vascular smooth muscle cell proliferative phenotype and neointimal hyperplasia.
Su C; Liu M; Yao X; Hao W; Ma J; Ren Y; Gao X; Xin L; Ge L; Yu Y; Wei M; Yang J
Cell Mol Life Sci; 2024 Jan; 81(1):59. PubMed ID: 38279051
[TBL] [Abstract][Full Text] [Related]
11. Alpha7 nicotinic acetylcholine receptor activation attenuated intestine-derived acute lung injury.
He Y; Ye ZQ; Li X; Zhu GS; Liu Y; Yao WF; Luo GJ
J Surg Res; 2016 Apr; 201(2):258-65. PubMed ID: 27020805
[TBL] [Abstract][Full Text] [Related]
12. IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation.
Ellison S; Gabunia K; Richards JM; Kelemen SE; England RN; Rudic D; Azuma YT; Munroy MA; Eguchi S; Autieri MV
Am J Pathol; 2014 Jul; 184(7):2134-43. PubMed ID: 24814101
[TBL] [Abstract][Full Text] [Related]
13. Sphigosine-1-phosphate receptor 1 promotes neointimal hyperplasia in a mouse model of carotid artery injury.
Kitano T; Usui S; Takashima SI; Inoue O; Goten C; Nomura A; Yoshioka K; Okajima M; Kaneko S; Takuwa Y; Takamura M
Biochem Biophys Res Commun; 2019 Mar; 511(1):179-184. PubMed ID: 30777331
[TBL] [Abstract][Full Text] [Related]
14. Neural anti-inflammatory action mediated by two types of acetylcholine receptors in the small intestine.
Kimura H; Imura YK; Tomiyasu H; Mihara T; Kaji N; Ohno K; Unno T; Tanahashi Y; Jan TR; Tsubone H; Ozaki H; Hori M
Sci Rep; 2019 Apr; 9(1):5887. PubMed ID: 30971711
[TBL] [Abstract][Full Text] [Related]
15. STAT4 deficiency protects against neointima formation following arterial injury in mice.
Lv L; Meng Q; Ye M; Wang P; Xue G
J Mol Cell Cardiol; 2014 Sep; 74():284-94. PubMed ID: 24933129
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats.
Zhang WX; Tai GJ; Li XX; Xu M
Free Radic Biol Med; 2019 Nov; 143():153-163. PubMed ID: 31369842
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor.
Zhang J; Zou F; Tang J; Zhang Q; Gong Y; Wang Q; Shen Y; Xiong L; Breyer RM; Lazarus M; Funk CD; Yu Y
Circ Res; 2013 Jul; 113(2):104-14. PubMed ID: 23595951
[TBL] [Abstract][Full Text] [Related]
18. Ketogenic diet inhibits neointimal hyperplasia by suppressing oxidative stress and inflammation.
Xu X; Xie L; Chai L; Wang X; Dong J; Wang J; Yang P
Clin Exp Hypertens; 2023 Dec; 45(1):2229538. PubMed ID: 37395230
[TBL] [Abstract][Full Text] [Related]
19. Effects of VAChT reduction and α7nAChR stimulation by PNU-282987 in lung inflammation in a model of chronic allergic airway inflammation.
Pinheiro NM; Miranda CJCP; Santana FR; Bittencourt-Mernak M; Arantes-Costa FM; Olivo C; Perini A; Festa S; Caperuto LC; Tibério IFLC; Prado MAM; Martins MA; Prado VF; Prado CM
Eur J Pharmacol; 2020 Sep; 882():173239. PubMed ID: 32619677
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
Yang J; Li S; Wang Q; Yang D
Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
